利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.013 秒)

    Use of Galectin-3 to promote the re-epithelialization of wounds
    2.
    发明授权
    Use of Galectin-3 to promote the re-epithelialization of wounds 失效
    使用半乳凝素-3促进伤口再上皮化

    公开(公告)号：US06967021B2

    公开(公告)日：2005-11-22

    申请号：US10133234

    申请日：2002-04-26

    申请人： Noorjahan Panjwani ,  Zhiyi Cao

    发明人： Noorjahan Panjwani ,  Zhiyi Cao

    IPC分类号： A61K38/17 ,  A61K39/00 ,  A61K38/00

    CPC分类号： A61K38/1709

    摘要： Methods for the therapeutic treatment of epithelial wounds in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-3 protein and/or a galectin-7 protein are provided. Pharmaceutical compositions comprising a pharmaceutically suitable carrier or diluent and as an active agent a galectin-3 protein and/or a galectin-7 protein are also provided.

    摘要翻译： 提供了哺乳动物上皮创伤的治疗性治疗方法，其包括向患有上皮损伤的哺乳动物施用治疗有效量的半乳凝素-3蛋白和/或半乳凝素-7蛋白。 还提供了包含药学上合适的载体或稀释剂以及作为活性剂的半乳凝素-3蛋白和/或半乳凝素-7蛋白的药物组合物。

    Use of galectin-7 to promote the re-epithelialization of wounds
    3.
    发明申请
    Use of galectin-7 to promote the re-epithelialization of wounds 审中-公开
    使用半乳凝素-7促进伤口再上皮化

    公开(公告)号：US20090270320A1

    公开(公告)日：2009-10-29

    申请号：US12380435

    申请日：2009-02-27

    申请人： Noorjahan Panjwani ,  Zhiyi Cao

    发明人： Noorjahan Panjwani ,  Zhiyi Cao

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1709

    摘要： Methods for the therapeutic treatment of epithelial wounds in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-3 protein and/or a galectin-7 protein are provided. Pharmaceutical compositions comprising a pharmaceutically suitable carrier or diluent and as an active agent a galectin-3 protein and/or a galectin-7 protein are also provided.

    摘要翻译： 提供了哺乳动物上皮创伤的治疗性治疗方法，其包括向患有上皮损伤的哺乳动物施用治疗有效量的半乳凝素-3蛋白和/或半乳凝素-7蛋白。 还提供了包含药学上合适的载体或稀释剂以及作为活性剂的半乳凝素-3蛋白和/或半乳凝素-7蛋白的药物组合物。

    Use of galectin-3 and galectin-7 to promote the re-epithelialization of wounds
    4.
    发明申请
    Use of galectin-3 and galectin-7 to promote the re-epithelialization of wounds 审中-公开
    使用半乳凝素-3和半乳凝素-7促进伤口再上皮化

    公开(公告)号：US20060035817A1

    公开(公告)日：2006-02-16

    申请号：US11211401

    申请日：2005-08-25

    申请人： Noorjahan Panjwani ,  Zhiyi Cao

    发明人： Noorjahan Panjwani ,  Zhiyi Cao

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1709

    摘要： Methods for the therapeutic treatment of epithelial wounds in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-3 protein and/or a galectin-7 protein are provided. Pharmaceutical compositions comprising a pharmaceutically suitable carrier or diluent and as an active agent a galectin-3 protein and/or a galectin-7 protein are also provided.

    摘要翻译： 提供了哺乳动物上皮创伤的治疗性治疗方法，其包括向患有上皮损伤的哺乳动物施用治疗有效量的半乳凝素-3蛋白和/或半乳凝素-7蛋白。 还提供了包含药学上合适的载体或稀释剂以及作为活性剂的半乳凝素-3蛋白和/或半乳凝素-7蛋白的药物组合物。

    Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome
    5.
    发明申请
    Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome 审中-公开
    用于治疗干眼综合征的半乳凝素的组成和用途

    公开(公告)号：US20100004163A1

    公开(公告)日：2010-01-07

    申请号：US11918393

    申请日：2006-04-13

    申请人： Noorjahan Panjwani

    发明人： Noorjahan Panjwani

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1732 ,  C07K14/4726

    摘要： Methods for the therapeutic treatment of dry eye in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-1 protein, a galectin-3, a galectin-7 protein and/or a galectin-8 protein are provided. Pharmaceutical and ophthalmic compositions and kits, comprising a pharmaceutically an active agent which is a galectin-1 protein, a galectin-3 protein, galectin-7 protein and/or a galectin-8 protein, and a suitable carrier or a diluent, are provided.

    摘要翻译： 用于治疗哺乳动物干眼症的方法包括向患有上皮创面的哺乳动物施用治疗有效量的半乳凝素-1蛋白，半乳凝素-3，半乳凝素-7蛋白和/或半乳凝素-8蛋白， 提供。 提供药物和眼用组合物和试剂盒，其包含药学活性剂，其为半乳凝素-1蛋白，半乳凝素-3蛋白，半乳凝素-7蛋白和/或半乳凝素-8蛋白，以及合适的载体或稀释剂 。

    Compositions and uses of a galectin for treatment of dry eye syndrome
    6.
    发明授权
    Compositions and uses of a galectin for treatment of dry eye syndrome 有权
    用于治疗干眼综合征的半乳凝素的组成和用途

    公开(公告)号：US07189697B2

    公开(公告)日：2007-03-13

    申请号：US11104677

    申请日：2005-04-13

    申请人： Noorjahan Panjwani

    发明人： Noorjahan Panjwani

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1732

    摘要： Methods for the therapeutic treatment of dry eye in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-1 protein, a galectin-3, a galectin-7 protein and/or a galectin-8 protein are provided. Pharmaceutical and ophthalmic compositions and kits, comprising a pharmaceutically an active agent which is a galectin-1 protein, a galectin-3 protein, galectin-7 protein and/or a galectin-8 protein, and a suitable carrier or a diluent, are provided.

    摘要翻译： 用于治疗哺乳动物干眼症的方法包括向患有上皮创面的哺乳动物施用治疗有效量的半乳凝素-1蛋白，半乳凝素-3，半乳凝素-7蛋白和/或半乳凝素-8蛋白， 提供。 提供药物和眼用组合物和试剂盒，其包含药学活性剂，其为半乳凝素-1蛋白，半乳凝素-3蛋白，半乳凝素-7蛋白和/或半乳凝素-8蛋白，以及合适的载体或稀释剂 。

    Compositions and uses of a galectin for treatment of dry eye syndrome
    7.
    发明申请
    Compositions and uses of a galectin for treatment of dry eye syndrome 有权
    用于治疗干眼综合征的半乳凝素的组成和用途

    公开(公告)号：US20060189514A1

    公开(公告)日：2006-08-24

    申请号：US11104677

    申请日：2005-04-13

    申请人： Noorjahan Panjwani

    发明人： Noorjahan Panjwani

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1732

    摘要： Methods for the therapeutic treatment of dry eye in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-1 protein, a galectin-3, a galectin-7 protein and/or a galectin-8 protein are provided. Pharmaceutical and ophthalmic compositions and kits, comprising a pharmaceutically an active agent which is a galectin-1 protein, a galectin-3 protein, galectin-7 protein and/or a galectin-8 protein, and a suitable carrier or a diluent, are provided.

    摘要翻译： 用于治疗哺乳动物干眼症的方法包括向患有上皮创面的哺乳动物施用治疗有效量的半乳凝素-1蛋白，半乳凝素-3，半乳凝素-7蛋白和/或半乳凝素-8蛋白， 提供。 提供药物和眼用组合物和试剂盒，其包含药学活性剂，其为半乳凝素-1蛋白，半乳凝素-3蛋白，半乳凝素-7蛋白和/或半乳凝素-8蛋白，以及合适的载体或稀释剂 。